142 related articles for article (PubMed ID: 11726126)
1. Proliferative activity in invasive breast carcinoma: a comprehensive comparison of MIB-1 immunocytochemical staining in aspiration biopsies to image analytic, flow cytometric and histologic parameters.
Ostrowski ML; Pindur J; Laucirica R; Chakraborty S; Ramzy I
Acta Cytol; 2001; 45(6):965-72. PubMed ID: 11726126
[TBL] [Abstract][Full Text] [Related]
2. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
3. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
[TBL] [Abstract][Full Text] [Related]
4. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
5. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
6. MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears.
Dalquen P; Baschiera B; Chaffard R; Dieterich H; Feichter GE; Krmer K; Torhorst J
Acta Cytol; 1997; 41(2):229-37. PubMed ID: 9100748
[TBL] [Abstract][Full Text] [Related]
7. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
8. MIB-1 index, S-phase fraction, mitotic figure count, and SBR histologic grading in invasive breast carcinoma: a comparative study.
El All HA; Ismail E; Abbas M; Ouf K
Breast J; 2001; 7(2):106-10. PubMed ID: 11328317
[TBL] [Abstract][Full Text] [Related]
9. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
Lehr HA; Hansen DA; Kussick S; Li M; Hwang H; Krummenauer F; Trouet S; Gown AM
Hum Pathol; 1999 Nov; 30(11):1314-20. PubMed ID: 10571511
[TBL] [Abstract][Full Text] [Related]
10. Cytometric DNA analysis and prognostic biomarkers in breast carcinoma. Expression of P53 product in the different ploidy classes.
Leonardi E; Cristofori A; Caffo O; Dalla Palma P
Anal Cell Pathol; 1997; 15(1):31-45. PubMed ID: 9373711
[TBL] [Abstract][Full Text] [Related]
11. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
[TBL] [Abstract][Full Text] [Related]
12. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
13. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.
Leonardi E; Dalla Palma P; Reich A; Caffo O; Luciani L
Anal Cell Pathol; 2000; 21(1):21-33. PubMed ID: 11254222
[TBL] [Abstract][Full Text] [Related]
14. Multiparameter absorption measurements in automated microscopy. Simultaneous quantitative determination of DNA and nuclear antigen.
Oud PS; Bauwens A; Nauwelaers FA
Acta Cytol; 1997; 41(1):188-96. PubMed ID: 9022743
[TBL] [Abstract][Full Text] [Related]
15. Proliferation assessment in breast cancer: a double-staining technique for AgNOR quantification in MIB-1 positive cells especially adapted for image cytometry.
Lorenzato M; Abboud P; Lechki C; Browarnyj F; O'Donohue MF; Ploton D; Adnet JJ
Micron; 2000 Apr; 31(2):151-9. PubMed ID: 10588061
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
[TBL] [Abstract][Full Text] [Related]
17. Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.
Ellis PA; Makris A; Burton SA; Titley J; Ormerod MG; Salter J; Powles TJ; Smith IE; Dowsett M
Br J Cancer; 1996 Mar; 73(5):640-3. PubMed ID: 8605100
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas.
Stanton KJ; Sidner RA; Miller GA; Cummings OW; Schmidt CM; Howard TJ; Wiebke EA
Am J Surg; 2003 Nov; 186(5):486-92. PubMed ID: 14599612
[TBL] [Abstract][Full Text] [Related]
19. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]